EUVIMEDEUVIMED entdecken
Crossref

Pharmacological potential of Astragali Radix for the treatment of kidney diseases

Yue Shi, Xiujie Shi, Mingming Zhao, Sijia Ma, Yu Zhang

Phytomedicine · 2024

DOI: 10.1016/j.phymed.2023.155196 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2024. Verfasst von Yue Shi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China. Hauptthemen laut MEDLINE: Astragalus Plant, Drugs, Chinese Herbal, Kidney Diseases, Saponins. Die Arbeit wurde bisher 68-mal zitiert (Crossref) und nennt 146 Literaturangaben. Gefördert von: Beijing Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: With the increasing prevalence of hypertension, diabetes, and obesity, the incidence of kidney diseases is also increasing, resulting in a serious public burden. Conventional treatments for kidney diseases have unsatisfactory effects and are associated with adverse reactions. Traditional Chinese medicines have good curative effects and advantages over conventional treatments for preventing and treating kidney diseases. Astragali Radix is a Chinese herbal medicine widely used to treat kidney diseases. PURPOSE: To review the potential applications and molecular mechanisms underlying the renal protective effects of Astragali Radix and its components and to provide direction and reference for new therapeutic strategies and future research and development of Astragali Radix. STUDY DESIGN AND METHODS: PubMed, Google Scholar, and Web of Science were searched using keywords, including "Astragali Radix," "Astragalus," "Astragaloside IV" (AS-IV), "Astragali Radix polysaccharide" (APS), and "kidney diseases." Reports on the effects of Astragali Radix and its components on kidney diseases were identified and reviewed. RESULTS: The main components of Astragali Radix with kidney-protective properties include AS-IV, APS, calycosin, formononetin, and hederagenin. Astragali Radix and its active components have potential pharmacological effects for the treatment of kidney diseases, including acute kidney injury, diabetic nephropathy, hypertensive renal damage, chronic glomerulonephritis, and kidney stones. The pharmacological effects of Astragali Radix are manifested through the inhibition of inflammation, oxidative stress, fibrosis, endoplasmic reticulum stress, apoptosis, and ferroptosis, as well as the regulation of autophagy. CONCLUSION: Astragali Radix is a promising drug candidate for treating kidney diseases. However, current research is limited to animal and cell studies, underscoring the need for further verifications using high-quality clinical data.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Astragalus PlantDrugs, Chinese HerbalKidney DiseasesSaponinsTriterpenesAnimalsMedicine, Chinese TraditionalPlant RootsInflammation

Stichwörter der Autor:innen

Astragali RadixAstragali Radix polysaccharideAstragaloside IVKidney diseasePharmacological potentials

Substanzen

Drugs, Chinese Herbalastragaloside ASaponinsTriterpenes

Autor:innen und Institutionen

  • Department of Nephrology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China.
  • Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China.
  • Department of Nephrology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China. Electronic address: zhangyu8225@126.com.

Förderung

  • Beijing Natural Science Foundation

Zitieren

APA

Shi, Y., Shi, X., Zhao, M., Ma, S., & Zhang, Y. (2024). Pharmacological potential of Astragali Radix for the treatment of kidney diseases. Phytomedicine. https://doi.org/10.1016/j.phymed.2023.155196

Vancouver

Shi Y, Shi X, Zhao M, Ma S, Zhang Y. Pharmacological potential of Astragali Radix for the treatment of kidney diseases. Phytomedicine. 2024. doi:10.1016/j.phymed.2023.155196

BibTeX
@article{Shi2024,
  author = {Shi, Yue and Shi, Xiujie and Zhao, Mingming and Ma, Sijia and Zhang, Yu},
  title = {Pharmacological potential of Astragali Radix for the treatment of kidney diseases},
  journal = {Phytomedicine},
  year = {2024},
  doi = {10.1016/j.phymed.2023.155196}
}
Kostenlos starten →